Subscribe to RSS
DOI: 10.1055/s-0036-1597556
Risk Stratification for Proven Acute Pulmonary Embolism: What Information Is Needed?
Publication History
Publication Date:
16 February 2017 (online)
![](https://www.thieme-connect.de/media/srccm/201701/lookinside/thumbnails/10-1055-s-0036-1597556_01229-1.jpg)
Abstract
Classification of risk drives treatment decisions for patients with acute symptomatic pulmonary embolism (PE). High-risk patients with acute symptomatic PE have hemodynamic instability (i.e., shock or hypotension present), and treatment guidelines suggest systemically administered thrombolytic therapy in this setting. Normotensive PE patients at low risk for early complications (low-risk PE) might benefit from treatment at home or early discharge, while normotensive patients with preserved systemic arterial pressure deemed as having a high risk for PE-related adverse clinical events (intermediate–high-risk PE) might benefit from close observation and consideration of escalation of therapy. Prognostic tools (e.g., clinical prognostic scoring systems, imaging testing, and cardiac laboratory biomarkers) assist with the classification of patients into these categories.
-
References
- 1 Jiménez D, de Miguel-Díez J, Guijarro R , et al; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 2016; 67 (2) 162-170
- 2 Laporte S, Mismetti P, Décousus H , et al; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117 (13) 1711-1716
- 3 Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279 (6) 458-462
- 4 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162): 1386-1389
- 5 Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41 (1) 3-14
- 6 Büller HR, Davidson BL, Decousus H , et al; Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349 (18) 1695-1702
- 7 The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337 (10) 657-662
- 8 Conget F, Otero R, Jiménez D , et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100 (5) 937-942
- 9 Klok FA, Zondag W, van Kralingen KW , et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010; 181 (5) 501-506
- 10 Kasper W, Konstantinides S, Geibel A , et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30 (5) 1165-1171
- 11 Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121 (3) 877-905
- 12 Kearon C, Akl EA, Ornelas J , et al. Antithrombotic therapy for VTE disease: CHEST guideline. Chest 2016; 149 (2) 315-352
- 13 Konstantinides SV, Torbicki A, Agnelli G , et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
- 14 Jaff MR, McMurtry MS, Archer SL , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
- 15 Jiménez D, Aujesky D, Yusen RD. Risk stratification of normotensive patients with acute symptomatic pulmonary embolism. Br J Haematol 2010; 151 (5) 415-424
- 16 Vanni S, Nazerian P, Pepe G , et al. Comparison of two prognostic models for acute pulmonary embolism: clinical vs. right ventricular dysfunction-guided approach. J Thromb Haemost 2011; 9 (10) 1916-1923
- 17 Lankeit M, Gómez V, Wagner C , et al; Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism. Chest 2012; 141 (4) 916-922
- 18 Bova C, Pesavento R, Marchiori A , et al; TELESIO Study Group. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost 2009; 7 (6) 938-944
- 19 Aujesky D, Obrosky DS, Stone RA , et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172 (8) 1041-1046
- 20 Aujesky D, Roy PM, Le Manach CP , et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27 (4) 476-481
- 21 Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost 2010; 8 (7) 1509-1514
- 22 Kohn CG, Mearns ES, Parker MW, Hernandez AV, Coleman CI. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest 2015; 147 (4) 1043-1062
- 23 Jiménez D, Aujesky D, Moores L , et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170 (15) 1383-1389
- 24 Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9 (10) 2115-2117
- 25 Zwierzina D, Limacher A, Méan M , et al. Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism. J Thromb Haemost 2012; 10 (11) 2270-2276
- 26 Aujesky D, Roy PM, Verschuren F , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378 (9785): 41-48
- 27 Zondag W, Mos IC, Creemers-Schild D , et al; Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9 (8) 1500-1507
- 28 den Exter PL, Zondag W, Klok FA , et al. Efficacy and safety of outpatient treatment based on the Hestia clinical decision rule with or without NT-proBNP tesing in patients with acute pulmonary embolism: a randomized clinical trial. Am J Respir Crit Care Med 2016; 194 (8) 998-1006
- 29 Zondag W, den Exter PL, Crobach MJ , et al; Hestia Study Investigators. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 2013; 109 (1) 47-52
- 30 Jiménez D, Lobo JL, Monreal M , et al; PROTECT investigators. Prognostic significance of multidetector CT in normotensive patients with pulmonary embolism: results of the protect study. Thorax 2014; 69 (2) 109-115
- 31 Marshall PS, Tapson V, Jiménez D. Controversies in the management of life-threatening pulmonary embolism. Semin Respir Crit Care Med 2015; 36 (6) 835-841
- 32 Meyer G, Vicaut E, Danays T , et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
- 33 Becattini C, Agnelli G, Vedovati MC , et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011; 32 (13) 1657-1663
- 34 Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004; 110 (20) 3276-3280
- 35 Becattini C, Agnelli G, Germini F, Vedovati MC. Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. Eur Respir J 2014; 43 (6) 1678-1690
- 36 Trujillo-Santos J, den Exter PL, Gómez V , et al. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost 2013; 11 (10) 1823-1832
- 37 Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134 (3) 479-487
- 38 Grifoni S, Olivotto I, Cecchini P , et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101 (24) 2817-2822
- 39 Lobo JL, Holley A, Tapson V , et al; PROTECT and RIETE investigators. Prognostic significance of tricuspid annular displacement in normotensive patients with acute symptomatic pulmonary embolism. J Thromb Haemost 2014; 12 (7) 1020-1027
- 40 Jiménez D. Point: should systemic lytic therapy be used for submassive pulmonary embolism? Yes. Chest 2013; 143 (2) 296-299
- 41 Sanchez O, Trinquart L, Colombet I , et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29 (12) 1569-1577
- 42 Jiménez D, Díaz G, Molina J , et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008; 31 (4) 847-853
- 43 Janata K, Holzer M, Laggner AN, Müllner M. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003; 326 (7384): 312-313
- 44 Lankeit M, Jiménez D, Kostrubiec M , et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 2011; 124 (24) 2716-2724
- 45 Dellas C, Puls M, Lankeit M , et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 2010; 55 (19) 2150-2157
- 46 Jiménez D, Uresandi F, Otero R , et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest 2009; 136 (4) 974-982
- 47 Jiménez D, Aujesky D, Díaz G , et al; RIETE Investigators. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2010; 181 (9) 983-991
- 48 Becattini C, Cohen AT, Agnelli G , et al. Risk stratification of patients with acute symptomatic pulmonary embolism based on the presence or absence of lower extremity DVT: systematic review and metaanalysis. Chest 2016; 149 (1) 192-200
- 49 Meinel FG, Nance Jr JW, Schoepf UJ , et al. Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis. Am J Med 2015; 128 (7) 747-59.e2
- 50 Binder L, Pieske B, Olschewski M , et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112 (11) 1573-1579
- 51 Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber SZ, Solomon SD. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96 (2) 303-305
- 52 Jiménez D, Aujesky D, Moores L , et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011; 66 (1) 75-81
- 53 Dellas C, Tschepe M, Seeber V , et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 2014; 111 (5) 996-1003
- 54 Jiménez D, Kopecna D, Tapson V , et al; On Behalf Of The Protect Investigators. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2014; 189 (6) 718-726
- 55 Bova C, Sanchez O, Prandoni P , et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J 2014; 44 (3) 694-703
- 56 Fernández C, Bova C, Sanchez O , et al. Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism. Chest 2015; 148 (1) 211-218
- 57 Hobohm L, Hellenkamp K, Hasenfuß G, Münzel T, Konstantinides S, Lankeit M. Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J 2016; 47 (4) 1170-1178